830
Keywords: implementation, pmtct of HIV, HIV therapy
INTRODUCTION
Globally, the year 2018 saw approximately 37.9 million individuals living with
HIV/AIDS, with a significant majority, roughly 69 percent (around 19.4 million),
located in sub-Saharan Africa (WHO/GHO, 2019). Despite the widespread
administration of progressive antiretroviral therapy, nearly 74 percent of the 1.5
million AIDS-related deaths in 2013 occurred in this region (Kharsany & Karim,
2016). In terms of gender, women worldwide have borne the heaviest burden of
HIV/AIDS (Ramjee & Daniels, 2013). Shockingly, it was estimated that a young
woman was infected with HIV almost every minute (UNAIDS, 2012). Sub-Saharan
Africa, in particular, has been severely impacted, with females accounting for at least
56–59% of People Living with HIV/AIDS (PLWHAs) (Kharsany & Karim, 2016;
Ramjee & Daniels, 2013; Sia et al., 2016). In the sub-region, young girls aged 15–19
years old make up 75% of new infections, and women in the 15–24 age group are
twice as likely to be living with HIV compared to their male counterparts (NACP,
2009). Furthermore, in 2017, 79% of HIV incidence in southern and eastern Africa
occurred among adolescent females aged 10–19 years (Brown et al., 2018).
According to data from the National AIDS Control Program (NACP) in 2018,
the female population in Ghana comprised 65% of the estimated 334,713 individuals
living with HIV/AIDS (PLWHAs), whereas males formed 35% of the total. The
gender difference in HIV infection and its consequences for women can be ascribed
to the unequal cultural and socio-economic standing they hold in comparison to men
(Higgins et al., 2010; Igulot & Magadi, 2018). Therefore, it is imperative to
implement interventions aimed at preventing or mitigating the transmission of HIV
from women to men or children, with a particular focus on pregnant women. The
transmission of HIV from mother to child, also known as mother-to-child
transmission (MTCT), continues to pose a substantial obstacle in the context of the
worldwide HIV pandemic. In the absence of preventative interventions, the
likelihood of HIV transmission to newborns throughout the course of pregnancy or
childbirth varies between 15 and 30 percent, and this risk escalates to a range of 20
to 45 percent when nursing is practiced. The implementation of Prevention of
Mother-to-Child Transmission (PMTCT) measures has proven effective in mitigating
vertical HIV transmission to below one percent in industrialized nations. However,
middle- and low-income countries have encountered very limited achievements in
this regard. Pregnant women who are infected with HIV face a significant risk of
transferring the virus to their offspring through mother-to-child transmission
(MTCT). This is a prominent issue in sub-Saharan African nations characterized by
elevated fertility rates and a high prevalence of HIV among women in their
reproductive years (UNAIDS and JC2137E, 2011). Mother-to-child transmission
(MTCT) is the primary cause of more than 90% of newly acquired HIV infections in
babies, as reported by the World Health Organization in 2007 (Petersen, 2008).
Prevention of mother-to-child transmission (PMTCT) is a holistic strategy
designed to encompass several interventions targeting the prevention, care,
treatment, and support services for mothers who are HIV-positive and their offspring,
spanning from the prenatal period to early childhood. According to Ngonyani et al.
(2012), this strategy has played a pivotal role in decreasing HIV infection rates among
the community and effectively eradicating HIV transmission to children on a global